Company family · HQ CH
Sandoz: medicine shortages
SDZ · SIX Swiss
As of 2 Nov 2026, 599 Sandoz products have a reported shortage across 13 countries, covering 198 medicines.
Products short599rank #3 of 464
Medicines198active ingredients
Countries13/16
New in 90 days252+69 vs market pace
Typical duration4 monthsmedian so far
Manufacturing59%demand-driven 22%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
When its current shortages began
Long-run trend in Canada
Canada dashboardCanada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Quetiapine | 35 | 13 Jun 2023 | Manufacturing problem | 12/16 | |
| Estradiol | 18 | 11 Feb 2026 | Manufacturing problem | 11/16 | |
| Atomoxetine | 17 | 31 Jul 2024 | Other | 11/16 | |
| Pregabalin | 17 | 6 Jan 2025 | Manufacturing problem | 11/16 | |
| Erythropoietin | 15 | 10 Jun 2024 | Manufacturing problem | 6/16 | |
| Duloxetine | 14 | 24 May 2024 | Manufacturing problem | 12/16 | |
| Adalimumab | 12 | 13 Jan 2026 | Not stated | 8/16 | |
| Zolmitriptan | 12 | 23 Apr 2024 | Manufacturing problem | 4/16 | |
| Sertraline | 10 | 16 Feb 2026 | Manufacturing problem | 11/16 | |
| Aripiprazole | 9 | 8 Jun 2026 | Manufacturing problem | 9/16 | |
| Bupropion | 9 | 10 Nov 2024 | Not stated | 7/16 | |
| Valsartan, amlodipine and hydrochlorothiazide | 9 | 1 Mar 2026 | Manufacturing problem | 2/16 | |
| Venlafaxine | 9 | 4 Apr 2025 | Manufacturing problem | 10/16 | |
| Dabigatran Etexilate | 7 | 30 Oct 2025 | Increased demand | 10/16 | |
| Glimepiride | 7 | 9 Jul 2026 | Manufacturing problem | 5/16 | |
| Rivaroxaban | 7 | 19 Nov 2025 | Manufacturing problem | 13/16 | |
| Allopurinol | 6 | 29 Oct 2025 | Manufacturing problem | 9/16 | |
| Fentanyl | 6 | 15 May 2026 | Not stated | 9/16 | |
| Gabapentin | 6 | 7 Apr 2026 | Commercial decision or withdrawal | 9/16 | |
| Metformin | 6 | 18 Mar 2025 | Increased demand | 8/16 | |
| Sumatriptan | 6 | 24 Jul 2026 | Increased demand | 13/16 | |
| Ampicillin | 5 | 8 Dec 2025 | Not stated | 2/16 | |
| Clindamycin | 5 | 21 Mar 2023 | Not stated | 4/16 | |
| Diclofenac | 5 | 18 Aug 2026 | Manufacturing problem | 10/16 | |
| Etanercept | 5 | 17 Aug 2026 | Manufacturing problem | 5/16 | |
| Itraconazole | 5 | 20 Apr 2026 | Manufacturing problem | 11/16 | |
| Mirtazapine | 5 | 24 Feb 2026 | Manufacturing problem | 10/16 | |
| Rabeprazole | 5 | 9 Jul 2026 | Manufacturing problem | 5/16 | |
| Tacrolimus | 5 | 3 Nov 2025 | Manufacturing problem | 6/16 | |
| Cefuroxime | 4 | 14 Jul 2026 | Distribution or logistics | 5/16 | |
| Enalapril | 4 | 2 Jul 2026 | Manufacturing problem | 8/16 | |
| Filgrastim | 4 | 30 Jul 2026 | Manufacturing problem | 4/16 | |
| Fluconazole | 4 | 9 May 2023 | Regulatory or licensing | 12/16 | |
| Memantine | 4 | 15 Jun 2026 | Manufacturing problem | 8/16 | |
| Olanzapine | 4 | 15 Sep 2026 | Increased demand | 13/16 | |
| Ramipril | 4 | 8 Sep 2026 | Manufacturing problem | 10/16 | |
| Risperidone | 4 | 22 Mar 2026 | Increased demand | 13/16 | |
| Simvastatin | 4 | 1 Sep 2026 | Manufacturing problem | 9/16 | |
| Trandolapril | 4 | 6 Jul 2026 | Manufacturing problem | 4/16 | |
| Valsartan and Amlodipine | 4 | 17 Aug 2026 | Manufacturing problem | 5/16 | |
| Zoledronic Acid | 4 | 10 Oct 2025 | Manufacturing problem | 7/16 | |
| Afatinib | 3 | 3 Aug 2026 | Active ingredient shortage | 1/16 | |
| Amoxicillin and Beta-Lactamase Inhibitor | 3 | 9 Jun 2023 | Manufacturing problem | 7/16 | |
| Caspofungin | 3 | 15 May 2026 | Not stated | 5/16 | |
| Ceftazidime | 3 | 24 Mar 2024 | Commercial decision or withdrawal | 5/16 | |
| Dexamethasone | 3 | 22 Sep 2025 | Increased demand | 1/16 | |
| Donepezil | 3 | 19 Oct 2026 | Manufacturing problem | 8/16 | |
| Doxycycline | 3 | 3 Jul 2026 | Manufacturing problem | 7/16 | |
| Finasteride | 3 | 20 Mar 2024 | Manufacturing problem | 8/16 | |
| Fluticasone, Combinations | 3 | 1 Sep 2026 | Distribution or logistics | 4/16 | |
| Fluvastatin | 3 | 27 Jan 2026 | Not stated | 2/16 | |
| Galantamine | 3 | 16 Oct 2025 | Not stated | 7/16 | |
| Ibandronic Acid | 3 | 29 May 2025 | Not stated | 4/16 | |
| Lamotrigine | 3 | 29 Jun 2026 | Active ingredient shortage | 9/16 | |
| Lidocaine | 3 | 11 Mar 2024 | Increased demand | 1/16 | |
| Loratadine | 3 | 16 Feb 2026 | Increased demand | 5/16 | |
| Mepivacaine | 3 | 24 Jul 2026 | Increased demand | 2/16 | |
| Nintedanib | 3 | 26 Aug 2026 | Increased demand | 4/16 | |
| Orlistat | 3 | 12 Aug 2026 | Manufacturing problem | 1/16 | |
| Pantoprazole | 3 | 20 Oct 2026 | Manufacturing problem | 9/16 | |
| Paroxetine | 3 | 23 Jul 2026 | Manufacturing problem | 8/16 | |
| Rifampicin | 3 | 16 Mar 2026 | Manufacturing problem | 8/16 | |
| Rifampicin and Isoniazid | 3 | 17 Feb 2026 | Not stated | 6/16 | |
| Risedronic Acid | 3 | 28 Sep 2026 | Increased demand | 3/16 | |
| Rosuvastatin | 3 | 17 Sep 2026 | Distribution or logistics | 12/16 | |
| Somatropin | 3 | 30 Oct 2025 | Other | 4/16 | |
| Sunitinib | 3 | 5 Oct 2026 | Manufacturing problem | 5/16 | |
| Tadalafil | 3 | 28 Oct 2026 | Manufacturing problem | 10/16 | |
| Theophylline | 3 | 25 Jul 2025 | Manufacturing problem | 3/16 | |
| Valsartan and Diuretics | 3 | 23 Sep 2026 | Manufacturing problem | 7/16 | |
| Zonisamide | 3 | 15 Oct 2026 | Quality problem or recall | 4/16 | |
| Acetylcysteine | 2 | 25 Aug 2026 | Increased demand | 6/16 | |
| Ambrisentan | 2 | 16 Oct 2025 | Not stated | 6/16 | |
| Amfetamine | 2 | not given | Not stated | 1/16 | |
| Amlodipine | 2 | 22 Sep 2026 | Other | 8/16 | |
| Benzathine Phenoxymethylpenicillin | 2 | 27 Mar 2026 | Not stated | 2/16 | |
| Bisoprolol and Thiazides | 2 | 5 Mar 2026 | Increased demand | 2/16 | |
| Bromazepam | 2 | 9 Oct 2024 | Increased demand | 4/16 | |
| Candesartan and Amlodipine | 2 | 26 Sep 2026 | Manufacturing problem | 3/16 | |
| Cefaclor | 2 | 14 Aug 2026 | Other | 4/16 | |
| Ciprofloxacin | 2 | 31 Mar 2026 | Manufacturing problem | 9/16 | |
| Deferasirox | 2 | 3 Aug 2026 | Increased demand | 8/16 | |
| Dimethyl Fumarate | 2 | 2 Mar 2026 | Manufacturing problem | 5/16 | |
| Ebastine | 2 | 15 Apr 2026 | Manufacturing problem | 4/16 | |
| Escitalopram | 2 | 19 Aug 2026 | Manufacturing problem | 10/16 | |
| Ezetimibe | 2 | 19 Aug 2026 | Manufacturing problem | 9/16 | |
| Flecainide | 2 | 7 Aug 2026 | Manufacturing problem | 5/16 | |
| Gliclazide | 2 | 3 Mar 2026 | Increased demand | 8/16 | |
| Irinotecan | 2 | 3 Nov 2025 | Not stated | 5/16 | |
| Ketoprofen | 2 | 19 Jun 2026 | Manufacturing problem | 4/16 | |
| Levetiracetam | 2 | 22 Sep 2026 | Manufacturing problem | 9/16 | |
| Levomethadone | 2 | 2 Sep 2026 | Regulatory or licensing | 2/16 | |
| Loperamide | 2 | 9 Jul 2026 | Manufacturing problem | 6/16 | |
| Losartan | 2 | 21 Aug 2024 | Not stated | 6/16 | |
| Metformin and Vildagliptin | 2 | 17 Aug 2026 | Distribution or logistics | 3/16 | |
| Norethisterone and Estrogen | 2 | 16 Apr 2026 | Increased demand | 2/16 | |
| Oxycodone and Naloxone | 2 | 30 Jul 2025 | Distribution or logistics | 2/16 | |
| Pazopanib | 2 | 30 May 2026 | Increased demand | 4/16 | |
| Phenoxymethylpenicillin | 2 | 23 Sep 2026 | Other | 5/16 | |
| Piperacillin and Beta-Lactamase Inhibitor | 2 | 2 Nov 2026 | Distribution or logistics | 8/16 | |
| Pirfenidone | 2 | 19 Oct 2026 | Manufacturing problem | 6/16 | |
| Pramipexole | 2 | 14 Sep 2026 | Manufacturing problem | 6/16 | |
| Rituximab | 2 | 6 Aug 2026 | Increased demand | 2/16 | |
| Rivastigmine | 2 | 17 Jun 2026 | Manufacturing problem | 6/16 | |
| Rocuronium Bromide | 2 | 15 Feb 2023 | Not stated | 5/16 | |
| Roflumilast | 2 | 30 Jun 2026 | Distribution or logistics | 1/16 | |
| Ropivacaine | 2 | 20 Apr 2026 | Increased demand | 9/16 | |
| Telmisartan and Diuretics | 2 | 19 Oct 2026 | Manufacturing problem | 4/16 | |
| Tenofovir Disoproxil | 2 | 2 Mar 2026 | Manufacturing problem | 6/16 | |
| Terbinafine | 2 | 28 Sep 2026 | Manufacturing problem | 5/16 | |
| Timolol | 2 | 13 May 2024 | Manufacturing problem | 7/16 | |
| Tolterodine | 2 | 30 Jan 2026 | Increased demand | 8/16 | |
| Topotecan | 2 | 28 Sep 2026 | Commercial decision or withdrawal | 5/16 | |
| Valproic Acid | 2 | 2 Apr 2026 | Manufacturing problem | 10/16 | |
| Vardenafil | 2 | 23 Jul 2026 | Manufacturing problem | 6/16 | |
| Vildagliptin | 2 | 20 Apr 2026 | Manufacturing problem | 3/16 | |
| Ziprasidone | 2 | 10 May 2026 | Manufacturing problem | 7/16 | |
| Abiraterone | 1 | 8 Jun 2026 | Distribution or logistics | 7/16 | |
| Alprazolam | 1 | 22 Sep 2026 | Manufacturing problem | 6/16 | |
| Amiodarone | 1 | 22 Sep 2025 | Other | 5/16 | |
| Anastrozole | 1 | 16 Nov 2026 | Manufacturing problem | 5/16 | |
| Atenolol | 1 | 1 Jan 2027 | Increased demand | 6/16 | |
| Axitinib | 1 | 9 Feb 2026 | Increased demand | 2/16 | |
| Azacitidine | 1 | 17 Mar 2026 | Not stated | 6/16 | |
| Betamethasone | 1 | 8 Dec 2025 | Manufacturing problem | 4/16 | |
| Bisoprolol | 1 | 28 Dec 2026 | Manufacturing problem | 6/16 | |
| Bosentan | 1 | 31 Jul 2026 | Manufacturing problem | 7/16 | |
| Buprenorphine | 1 | 5 May 2026 | Regulatory or licensing | 7/16 | |
| Buprenorphine | 1 | 11 May 2026 | Not stated | 4/16 | |
| Cabazitaxel | 1 | 6 Oct 2026 | Manufacturing problem | 2/16 | |
| Candesartan and Diuretics | 1 | 27 Oct 2026 | Manufacturing problem | 5/16 | |
| Capecitabine | 1 | 15 Feb 2025 | Manufacturing problem | 6/16 | |
| Carboplatin | 1 | 19 Oct 2026 | Not stated | 10/16 | |
| Carvedilol | 1 | 1 Nov 2026 | Increased demand | 8/16 | |
| Ciclosporin | 1 | 10 Nov 2025 | Manufacturing problem | 6/16 | |
| Cilostazol | 1 | 14 Sep 2026 | Manufacturing problem | 2/16 | |
| Colecalciferol | 1 | 15 May 2026 | Increased demand | 8/16 | |
| Daptomycin | 1 | 13 Oct 2026 | Manufacturing problem | 5/16 | |
| Dasatinib | 1 | 30 Sep 2026 | Distribution or logistics | 6/16 | |
| Desloratadine | 1 | 19 Aug 2026 | Manufacturing problem | 7/16 | |
| Dexamethasone | 1 | 26 Oct 2026 | Increased demand | 10/16 | |
| Diltiazem | 1 | 20 Nov 2025 | Manufacturing problem | 7/16 | |
| Efavirenz | 1 | 3 Jun 2026 | Manufacturing problem | 3/16 | |
| Erlotinib | 1 | 13 Oct 2026 | Other | 5/16 | |
| Etoposide | 1 | 2 Nov 2026 | Manufacturing problem | 7/16 | |
| Etoricoxib | 1 | 29 May 2026 | Not stated | 7/16 | |
| Febuxostat | 1 | 19 Jun 2026 | Increased demand | 6/16 | |
| Felodipine | 1 | 15 Sep 2026 | Increased demand | 5/16 | |
| Folic Acid | 1 | not given | Not stated | 3/16 | |
| Furosemide | 1 | 25 Mar 2026 | Manufacturing problem | 11/16 | |
| Gemcitabine | 1 | 15 Dec 2026 | Manufacturing problem | 9/16 | |
| Glyceryl Trinitrate | 1 | not given | Not stated | 6/16 | |
| Irbesartan and Diuretics | 1 | 12 Aug 2026 | Manufacturing problem | 4/16 | |
| Isotretinoin | 1 | 4 May 2026 | Not stated | 4/16 | |
| Lacosamide | 1 | 1 Mar 2026 | Manufacturing problem | 6/16 | |
| Lactulose | 1 | 24 Sep 2026 | Increased demand | 3/16 | |
| Leflunomide | 1 | 13 Jul 2026 | Increased demand | 3/16 | |
| Lenalidomide | 1 | 19 Aug 2026 | Manufacturing problem | 10/16 | |
| Letrozole | 1 | 26 Jun 2026 | Increased demand | 6/16 | |
| Leuprorelin | 1 | 9 Jul 2026 | Manufacturing problem | 5/16 | |
| Levocetirizine | 1 | 18 Sep 2026 | Increased demand | 4/16 | |
| Levodopa and Decarboxylase Inhibitor | 1 | 2 Sep 2026 | Distribution or logistics | 4/16 | |
| Levonorgestrel and Ethinylestradiol | 1 | 30 Nov 2025 | Manufacturing problem | 3/16 | |
| Losartan and Diuretics | 1 | 15 Jul 2026 | Other | 4/16 | |
| Macrogol, Combinations | 1 | 11 Feb 2026 | Not stated | 7/16 | |
| Magnesium Sulfate | 1 | 12 Jun 2026 | Other | 3/16 | |
| Methotrexate | 1 | 1 Aug 2021 | Active ingredient shortage | 6/16 | |
| Mitoxantrone | 1 | 24 Aug 2026 | Manufacturing problem | 1/16 | |
| Montelukast | 1 | 29 Oct 2026 | Manufacturing problem | 13/16 | |
| Mycophenolic Acid | 1 | 4 Sep 2026 | Not stated | 6/16 | |
| Natalizumab | 1 | 29 Oct 2026 | Manufacturing problem | 1/16 | |
| Olmesartan Medoxomil | 1 | 14 Sep 2026 | Increased demand | 5/16 | |
| Omeprazole | 1 | 10 Sep 2026 | Manufacturing problem | 8/16 | |
| Ondansetron | 1 | 3 Jun 2026 | Manufacturing problem | 9/16 | |
| Oxcarbazepine | 1 | 9 May 2025 | Other | 4/16 | |
| Paliperidone | 1 | 13 Feb 2026 | Increased demand | 11/16 | |
| Paracetamol | 1 | 28 Sep 2026 | Manufacturing problem | 10/16 | |
| Ramipril and Amlodipine | 1 | 19 Aug 2026 | Manufacturing problem | 3/16 | |
| Rifampicin, Pyrazinamide, Ethambutol and Isoniazid | 1 | 24 Aug 2026 | Not stated | 1/16 | |
| Riluzole | 1 | 9 Jul 2026 | Increased demand | 6/16 | |
| Ritonavir | 1 | 16 Feb 2026 | Manufacturing problem | 6/16 | |
| Sildenafil | 1 | 25 Aug 2026 | Manufacturing problem | 10/16 | |
| Simvastatin and Ezetimibe | 1 | 15 Oct 2026 | Increased demand | 8/16 | |
| Sodium Phosphate | 1 | 12 Jun 2026 | Other | 2/16 | |
| Solifenacin | 1 | 24 Jul 2026 | Manufacturing problem | 6/16 | |
| Sorafenib | 1 | 7 Jul 2026 | Manufacturing problem | 6/16 | |
| Sotalol | 1 | 22 Sep 2026 | Manufacturing problem | 2/16 | |
| Sulpiride | 1 | 11 Aug 2026 | Distribution or logistics | 1/16 | |
| Tenofovir Disoproxil and Emtricitabine | 1 | 11 May 2026 | Not stated | 5/16 | |
| Teriflunomide | 1 | 31 May 2026 | Increased demand | 4/16 | |
| Tizanidine | 1 | 22 Sep 2026 | Manufacturing problem | 4/16 | |
| Topiramate | 1 | 27 Oct 2026 | Manufacturing problem | 8/16 | |
| Travoprost | 1 | 13 Jul 2026 | Manufacturing problem | 7/16 | |
| Valaciclovir | 1 | 2 Nov 2026 | Manufacturing problem | 10/16 | |
| Valganciclovir | 1 | 6 Aug 2026 | Increased demand | 5/16 | |
| Voriconazole | 1 | 19 Aug 2026 | Manufacturing problem | 6/16 | |
| Zolpidem | 1 | 7 Oct 2026 | Manufacturing problem | 6/16 | |
| naproxen and esomeprazole | 1 | 7 Oct 2026 | Increased demand | 2/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.